Beate Wieseler

Summary

Country: Germany

Publications

  1. ncbi [Results registries for clinical trials--a milestone on the way to transparency in clinical research?]
    Beate Wieseler
    Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, Koln
    Z Evid Fortbild Qual Gesundhwes 104:298-305. 2010
  2. ncbi Access to regulatory data from the European Medicines Agency: the times they are a-changing
    Beate Wieseler
    Institute for Quality and Efficiency in Health Care, Im Mediapark 8 KölnTurm, Cologne, 50670, Germany
    Syst Rev 1:50. 2012
  3. ncbi Impact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications
    Beate Wieseler
    Institute for Quality and Efficiency in Health Care, Dillenburger Strasse 27, 51105 Cologne, Germany
    BMJ 344:d8141. 2012
  4. ncbi Reporting bias in medical research - a narrative review
    Natalie McGauran
    Institute for Quality and Efficiency in Health Care, Dillenburger Str 27, 51105 Cologne, Germany
    Trials 11:37. 2010

Collaborators

Detail Information

Publications4

  1. ncbi [Results registries for clinical trials--a milestone on the way to transparency in clinical research?]
    Beate Wieseler
    Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, Koln
    Z Evid Fortbild Qual Gesundhwes 104:298-305. 2010
    ..The present paper describes the status quo of results registries, discusses registration requirements, and outlines the need to develop methods for the handling of results registries...
  2. ncbi Access to regulatory data from the European Medicines Agency: the times they are a-changing
    Beate Wieseler
    Institute for Quality and Efficiency in Health Care, Im Mediapark 8 KölnTurm, Cologne, 50670, Germany
    Syst Rev 1:50. 2012
    ..In conclusion, regulatory data are an indispensable source for systematic reviews. Because of EMA's policy change, a milestone for data transparency in clinical research is within reach; let's hope it is not unnecessarily delayed...
  3. ncbi Impact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications
    Beate Wieseler
    Institute for Quality and Efficiency in Health Care, Dillenburger Strasse 27, 51105 Cologne, Germany
    BMJ 344:d8141. 2012
    ..To investigate to what extent three types of documents for reporting clinical trials provide sufficient information for trial evaluation...
  4. ncbi Reporting bias in medical research - a narrative review
    Natalie McGauran
    Institute for Quality and Efficiency in Health Care, Dillenburger Str 27, 51105 Cologne, Germany
    Trials 11:37. 2010
    ..This will allow for an independent review of research data, help fulfil ethical obligations towards patients, and ensure a basis for fully-informed decision making in the health care system...